AMBEY — Ambey Laboratories Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapValue Trap

Annual income statement for Ambey Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	817	846	1,048	1,205	1,313
Cost of Revenue
Gross Profit	154	157	149	138	143
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	752	772	994	1,142	1,242
Operating Profit	65.1	73.7	54.4	62.6	70.4
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	30.9	48.3	62.2	54.3	60.4
Provision for Income Taxes
Net Income After Taxes	103	35.7	45.7	77.2	47.8
Net Income Before Extraordinary Items
Net Income	103	35.7	45.7	77.2	47.8
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	103	35.7	45.7	77.2	47.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.14	1.43	1.83	4.35	2.06